Hyrobotics Secures 25 Billion Won in Series A Funding

Hyrobotics has raised 25 billion won in a Series A funding round. The company reported that the investment brings its total funding to over 33.5 billion won. The capital will be allocated to expanding the overseas business for medical walking rehabilitation robots and developing daily walking assistance devices. StartupN reported the story.

The round included participation from Atinum Investment as a key investor. Most existing major investors, including Stonebridge Venture, Ajou IB Investment, Wonik Investment Partners, Mirae Asset Venture Investment, and Doosan Investment, participated in the follow-on investment. New strategic investors joined the round, including Daewoong, Naver, and Lotte, alongside the Industrial Bank of Korea.

The company plans to collaborate with these strategic investors to expand hospital supply and distribution networks, enter overseas markets, and enhance its data and software platform. The goal is to broaden its scope beyond medical rehabilitation robots to support daily walking and utilize wearer movement data.

Hyrobotics, founded in July 2022, specializes in soft exosuits. Its main product, H-Medi, is a soft exosuit certified as a Class II combination medical device by the Ministry of Food and Drug Safety. It uses cable and tendon drive technology to be worn like clothing and analyzes walking status in real-time to assist with necessary force. The device was commercialized in September 2025 and has been adopted by hospitals including Severance Hospital, Chung-Ang University Hospital, and Korea University Hospital. It was also exported to the University of Illinois Chicago in June for stroke patient rehabilitation research and physical therapist education.

The company is also pursuing market entry in Japan and Southeast Asia. The new funds will be used for H-Medi's overseas regulatory approvals, distribution expansion, and the development and mass production of H-Care, a daily walking assistance robot. Long-term plans include developing personalized walking algorithms and software services for predicting muscle loss and fall risks, aiming to expand into a data platform business combining wearable robots with physical AI. The company employs approximately 47 people, with about 45 percent holding master's or doctoral degrees.